Knocking at the Doors of Perception: Relating LSD Effects on Low-Frequency Fluctuations and Regional Homogeneity to Receptor Densities in fMRI.
The publication of this research in the European Journal of Neuroscience marks a significant milestone in the field of neuropharmacology, as a team of Italian researchers has provided a detailed…
Glucagon-like peptide-1 receptor agonist use and violent crime among US adults.
The rapid proliferation of Glucagon-like peptide-1 (GLP-1) receptor agonists, marketed under brand names such as Ozempic and Wegovy, has already fundamentally altered the landscape of metabolic health and obesity treatment…
GLP-1 Receptor Agonists Show Remarkable Mental Health Benefits, Large-Scale Study Reveals
Medications commonly prescribed for type 2 diabetes and obesity, including prominent brands such as Ozempic and Wegovy, are demonstrating an unexpected and significant positive impact on mental health. A comprehensive…
Unlocking Ketamine’s Secrets: New PET Imaging Reveals Brain Receptor Dynamics in Treatment-Resistant Depression
Major depressive disorder (MDD) continues to cast a long shadow over global public health, recognized as a significant contributor to disability worldwide. For a substantial portion of individuals diagnosed with…
An exploration of the relationships between the effects of psilocybin on behavior, 5-HT2A receptor occupancy, and neuroplastic effects in mice.
The therapeutic potential of psychedelic compounds has transitioned from the fringes of counterculture to the forefront of psychiatric research, driven by a global mental health crisis that has left millions…


The Hidden Environmental Cost of the Puffer Jacket: Unpacking the Footprint of a Cold-Weather Staple









